Each unit consists of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. When trading begins on March 18, the ordinary shares and Series A Warrants will trade separately on the Nasdaq Capital Market under the symbols “CHEK” and “CHEKW” respectively.
Check-Cap is a clinical stage medical diagnostics company focused on the development of gastrointestinal imaging devices, including a preparation-free ingestible imaging capsule.
More articles on GI/endoscopy:
The Endoscopy Center to sign pledge for increasing CRC screening rates nationwide
Olympus faces 5 lawsuits in wake of UCLA outbreak
Dr. Daniel Podolsky to join Agilent Technologies board of directors
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.